Society is fascinated with health, fitness and longevity. This obsession has spawned a multi-million pound industry centred around pushing the latest cutting-edge science, lifestyle modifications and ...

Simple interest is paid only on the principal, e.g., a $10,000 investment at 5% yields $500 annually. Compound interest accumulates on both principal and past interest, increasing total returns over ...

About The Study: In contrast to earlier studies, this meta-analysis found significantly higher treatment failure and major complication rates within a year with nonoperative management among children ...

When I lived with my parents, my mother said she could always tell when my period was approaching: I raided the snack cupboard a little more frequently and became a lot more irritable. I remember all ...

Q I had a pain on the right side of my abdomen. A CT scan found a perforated appendix with an abscess. I was treated with IV antibiotics, and now I am feeling fine. Do I need to have my appendix taken ...

With three new antibiotics set to shake up the stagnant treatment landscape for uncomplicated urinary tract infections (uUTIs) in the U.S., Dublin-based Iterum Therapeutics has made it to market first ...

Simple game designs can offer immediate fun and easy learning curves, catering to a wide range of gamers. Immersive horror experiences like Lethal Company excel with streamlined structures despite ...

The FDA has assigned a Prescription Drug User Fee Act goal date of December 11, 2025 to make a decision on the application. The Food and Drug Administration (FDA) has accepted for Priority Review the ...

Discover What’s Streaming On: Blake Lively is a movie star. As unlikely as it might seem that anyone who got their big break on The CW would reach that status in the 2020s, when most of the most ...

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes. Study participants were randomly ...

GSK's Blujepa met primary endpoints in phase 3 trials, showing 58.5% success in EAGLE-3 vs. 43.6% for nitrofurantoin in uUTI treatment. The FDA approved Blujepa for uUTIs in female adults and ...

Panelists discuss how their practices have observed an increasing trend in uncomplicated urinary tract infections (UTIs), particularly among younger adult women and those with recurrent infections, ...